BUY
₹14,049
₹14,725
₹17,800
26.70%
Anand Rathi Research maintained its BUY view on Dixon Technologies in its August 2, 2026 result update and raised the target price to Rs 17,800. The broker considers approval of the Vivo joint venture and PLI 2.0 to be important catalysts for Dixon's medium-term growth.
The Vivo joint venture is expected to add about 9 million smartphone units in FY27E and about 22 million units in FY28E. Additional growth opportunities are expected from the Longcheer joint venture, exports, and continued momentum in Telecom & Networking and IT Hardware. Strong balance-sheet quality, cash generation and industry-leading return ratios support the broker's view that Dixon deserves premium valuations.
Dixon reported Q1FY27 revenue of Rs 155,477 million, up 21.1 per cent year on year and 11.7 per cent above Anand Rathi's estimate. Growth was aided by higher smartphone average selling prices amid elevated memory prices. EBITDA declined 4.0 per cent year on year to Rs 4,631 million, broadly in line with the broker's estimate.
| Metric | Q1FY27 | Year-on-year change | Comparison |
|---|---|---|---|
| Revenue | Rs 155,477 million | +21.1% | 11.7% above Anand Rathi estimate |
| EBITDA | Rs 4,631 million | -4.0% | Broadly in line with estimate |
| EBITDA margin | 3.0% | Down 78 basis points | Affected by Mobile PLI 1.0 expiry and higher handset ASPs |
| Adjusted PAT | Rs 2,358 million | +4.8% | 26.7% above Anand Rathi estimate; 3.3% above Bloomberg consensus |
The decline in EBITDA margin reflected the expiry of Mobile PLI 1.0 and higher handset average selling prices, which created optical dilution. Absolute EBITDA per handset was largely unchanged. Reported results also included a one-off fair-value gain of Rs 5,200 million on Dixon's Aditya Infotech stake.
Management indicated that smartphone volume excluding Vivo should remain broadly flat at about 32-33 million units in FY27E, despite an expected double-digit contraction in the industry. This implies market-share gains for Dixon. The Q2 smartphone order book stood at about 9-9.2 million units, with management guiding to 20-25 per cent quarter-on-quarter volume growth.
Approval for the Vivo joint venture was received in July 2026. Transaction closure is expected within about two months, and revenue contribution should begin in Q3FY27. Management expects mobile margins to remain under pressure through FY27 because of high memory prices and the expiry of Mobile PLI. Margin recovery from FY28 is expected to be supported by display and camera localisation and benefits from PLI 2.0 or ECMS.
PLI 2.0 is expected to reward brand-wise incremental production and localisation. Incentives are understood to be about 2.5-5.0 per cent on incremental production and about 1.5 per cent for localisation of components.
Following Q1FY27, Anand Rathi raised its FY27E and FY28E adjusted PAT estimates by 17.9 per cent and 15.5 per cent, respectively, to reflect the Vivo joint venture.
| Forecast metric | FY26-28E outlook |
|---|---|
| Revenue CAGR | 42.3% |
| EBITDA CAGR | 45.9% |
| PAT CAGR | 47.9% |
| RoCE | Expected to rise by 1,190 basis points to 36.6% |
The target price is based on 55 times FY28E EPS, raised from 45 times because of improved earnings visibility following Vivo approval and the PLI 2.0 rollout.
Disclaimer: This is a summary of a research report published by the broker/research house identified above. The views, recommendations, target prices and estimates are those of the respective broker and do not represent DSIJ investment advice. The summary may be AI-assisted, hence please refer to the original report for complete details, disclosures and risks.
Copyright 2026 by DSIJ Wealth Advisory Pvt. Ltd. (Formerly Known as DSIJ Pvt. Ltd.)